Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
MannKind Corp
MNKD
$1.27B
| $11.8M | 0.01% |
2,717,019
+226,234
| +9% | +$1.02M |
|
1827
CALL
Yum! Brands
YUM
$43.3B
| $11.8M | 0.01% |
96,600
| – | – |
|
1828
Walker & Dunlop
WD
$1.68B
| $11.8M | 0.01% |
104,064
+59,743
| +135% | +$6.26M |
|
|
HEPS
1829
D-Market Electronic Services & Trading
HEPS
$1.04B
| $11.8M | 0.01% |
+1,720,063
| New | +$18.7M |
|
1830
Nektar Therapeutics
NKTR
$2.41B
| $11.8M | 0.01% |
43,797
+5,371
| +14% | +$1.29M |
|
|
CTOS.WS
1831
CALL
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
| $11.8M | 0.01% |
5,410,617
+1,158,071
| +27% | +$2.26M |
|
|
TBCP
1832
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
| $11.8M | 0.01% |
1,206,671
-266,615
| -18% | -$2.59M |
|
|
JNPR
1833
DELISTED
Juniper Networks
JNPR
| $11.8M | 0.01% |
427,518
-1,762,005
| -80% | -$49.6M |
|
1834
Domo
DOMO
$174M
| $11.8M | 0.01% |
139,311
+33,356
| +31% | +$2.86M |
|
|
NSTC
1835
DELISTED
Northern Star Investment Corp. III
NSTC
| $11.8M | 0.01% |
1,206,879
+751,514
| +165% | +$7.31M |
|
|
BSKYU
1836
DELISTED
Big Sky Growth Partners, Inc. Unit
BSKYU
| $11.7M | 0.01% |
1,175,962
-147,697
| -11% | -$1.47M |
|
|
OCA
1837
DELISTED
Omnichannel Acquisition Corp.
OCA
| $11.7M | 0.01% |
1,184,900
+227,094
| +24% | +$2.24M |
|
1838
ASE Group
ASX
$76.5B
| $11.7M | 0.01% |
1,493,688
+921,004
| +161% | +$8M |
|
|
SPAQ
1839
DELISTED
Spartan Acquisition Corp. III
SPAQ
| $11.7M | 0.01% |
1,186,351
+467,411
| +65% | +$4.6M |
|
|
SGFY
1840
DELISTED
Signify Health, Inc.
SGFY
| $11.7M | 0.01% |
+655,026
| New | +$16.8M |
|
1841
AMC Entertainment Holdings
AMC
$2.47B
| $11.7M | 0.01% |
+30,744
| New | +$12.4M |
|
1842
PUT
Teva Pharmaceuticals
TEVA
$41.2B
| $11.7M | 0.01% |
1,200,000
+490,000
| +69% | +$4.59M |
|
|
FTCV
1843
DELISTED
FinTech Acquisition Corp. V Class A Common Stock
FTCV
| $11.7M | 0.01% |
1,153,767
+586,325
| +103% | +$6.19M |
|
1844
Puma Biotechnology
PBYI
$402M
| $11.7M | 0.01% |
1,666,785
+1,010,130
| +154% | +$7.56M |
|
1845
PUT
International Flavors & Fragrances
IFF
$20.3B
| $11.7M | 0.01% |
87,300
-33,300
| -28% | -$4.89M |
|
1846
Commault Systems
CVLT
$4.82B
| $11.7M | 0.01% |
154,806
+27,371
| +21% | +$2.12M |
|
1847
RLI Corp
RLI
$5.62B
| $11.7M | 0.01% |
232,422
+98,728
| +74% | +$5.25M |
|
1848
Goldman Sachs BDC
GSBD
$975M
| $11.6M | 0.01% |
632,173
+375,182
| +146% | +$7.18M |
|
1849
Sabesp
SBS
$19.2B
| $11.6M | 0.01% |
8,445,512
+4,558,804
| +117% | +$6.05M |
|
1850
Unifirst Corp
UNF
$5.31B
| $11.6M | 0.01% |
54,506
+653
| +1% | +$144K |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.